ROIV logo

Roivant Sciences (ROIV) Cash from operations

annual CFO:

-$839.45M-$74.18M(-9.69%)
March 1, 2025

Summary

  • As of today (June 28, 2025), ROIV annual cash flow from operations is -$839.45 million, with the most recent change of -$74.18 million (-9.69%) on March 1, 2025.
  • During the last 3 years, ROIV annual CFO has fallen by -$161.72 million (-23.86%).
  • ROIV annual CFO is now -52.04% below its all-time high of -$552.14 million, reached on March 31, 2021.

Performance

ROIV Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherROIVcash flow metrics

quarterly CFO:

-$172.56M+$34.69M(+16.74%)
March 1, 2025

Summary

  • As of today (June 28, 2025), ROIV quarterly cash flow from operations is -$172.56 million, with the most recent change of +$34.69 million (+16.74%) on March 1, 2025.
  • Over the past year, ROIV quarterly CFO has dropped by -$64.11 million (-59.11%).
  • ROIV quarterly CFO is now -76.01% below its all-time high of -$98.05 million, reached on September 30, 2020.

Performance

ROIV quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherROIVcash flow metrics

TTM CFO:

-$839.45M-$64.11M(-8.27%)
March 1, 2025

Summary

  • As of today (June 28, 2025), ROIV TTM cash flow from operations is -$839.45 million, with the most recent change of -$64.11 million (-8.27%) on March 1, 2025.
  • Over the past year, ROIV TTM CFO has dropped by -$74.18 million (-9.69%).
  • ROIV TTM CFO is now -655.13% below its all-time high of -$111.17 million, reached on June 1, 2020.

Performance

ROIV TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherROIVcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ROIV Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.7%-59.1%-9.7%
3 y3 years-23.9%-17.0%-23.9%
5 y5 years-52.0%-55.2%-655.1%

ROIV Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-23.9%+0.5%-59.1%+35.3%-23.9%+2.1%
5 y5-year-52.0%+0.5%-76.0%+35.7%-655.1%+2.1%
alltimeall time-52.0%+0.5%-76.0%+35.7%-655.1%+2.1%

ROIV Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-$839.45M(+9.7%)
-$172.56M(-16.7%)
-$839.45M(+8.3%)
Dec 2024
-
-$207.25M(-22.3%)
-$775.34M(-0.4%)
Sep 2024
-
-$266.81M(+38.4%)
-$778.54M(+9.9%)
Jun 2024
-
-$192.83M(+77.8%)
-$708.16M(-7.5%)
Mar 2024
-$765.27M(-9.3%)
-$108.46M(-48.5%)
-$765.27M(-8.4%)
Dec 2023
-
-$210.45M(+7.1%)
-$835.90M(-1.4%)
Sep 2023
-
-$196.43M(-21.4%)
-$848.04M(+0.8%)
Jun 2023
-
-$249.93M(+39.6%)
-$841.24M(-0.3%)
Mar 2023
-$843.39M
-$179.09M(-19.5%)
-$843.39M(+3.9%)
Dec 2022
-
-$222.59M(+17.4%)
-$811.77M(-5.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$189.63M(-24.8%)
-$857.67M(+8.8%)
Jun 2022
-
-$252.08M(+70.9%)
-$788.64M(+16.4%)
Mar 2022
-$677.73M(+22.7%)
-$147.47M(-45.1%)
-$677.73M(+6.5%)
Dec 2021
-
-$268.49M(+122.6%)
-$636.33M(+5.2%)
Sep 2021
-
-$120.60M(-14.6%)
-$604.69M(+3.9%)
Jun 2021
-
-$141.17M(+33.1%)
-$582.14M(+5.4%)
Mar 2021
-$552.14M
-$106.07M(-55.2%)
-$552.14M(+23.8%)
Dec 2020
-
-$236.86M(+141.6%)
-$446.07M(+113.2%)
Sep 2020
-
-$98.05M(-11.8%)
-$209.21M(+88.2%)
Jun 2020
-
-$111.17M
-$111.17M

FAQ

  • What is Roivant Sciences annual cash flow from operations?
  • What is the all time high annual CFO for Roivant Sciences?
  • What is Roivant Sciences annual CFO year-on-year change?
  • What is Roivant Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Roivant Sciences?
  • What is Roivant Sciences quarterly CFO year-on-year change?
  • What is Roivant Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Roivant Sciences?
  • What is Roivant Sciences TTM CFO year-on-year change?

What is Roivant Sciences annual cash flow from operations?

The current annual CFO of ROIV is -$839.45M

What is the all time high annual CFO for Roivant Sciences?

Roivant Sciences all-time high annual cash flow from operations is -$552.14M

What is Roivant Sciences annual CFO year-on-year change?

Over the past year, ROIV annual cash flow from operations has changed by -$74.18M (-9.69%)

What is Roivant Sciences quarterly cash flow from operations?

The current quarterly CFO of ROIV is -$172.56M

What is the all time high quarterly CFO for Roivant Sciences?

Roivant Sciences all-time high quarterly cash flow from operations is -$98.05M

What is Roivant Sciences quarterly CFO year-on-year change?

Over the past year, ROIV quarterly cash flow from operations has changed by -$64.11M (-59.11%)

What is Roivant Sciences TTM cash flow from operations?

The current TTM CFO of ROIV is -$839.45M

What is the all time high TTM CFO for Roivant Sciences?

Roivant Sciences all-time high TTM cash flow from operations is -$111.17M

What is Roivant Sciences TTM CFO year-on-year change?

Over the past year, ROIV TTM cash flow from operations has changed by -$74.18M (-9.69%)
On this page